High expression levels of several tumor-associated antigens (including CD20, CD19, and CD22) in CLL are correlated with a high proliferation rate and disease progression and modulate BCR-dependent and BCR-independent proliferation/survival signals [6]. Here, BCR is linked to neoplasm.